Patents Examined by Mina Haghighatian
  • Patent number: 10406105
    Abstract: Pharmaceutical formulation in the form of agglomerates comprising A) an excipient content composed of a) 60-97% by weight of sugar or sugar alcohols, b) 1-25% by weight of a disintegrant, c) 1-15% by weight of water-insoluble, film-forming polymers d) 0-15% by weight of water-soluble polymers and e) 0-15% by weight of further pharmaceutically customary excipients the total of the components a) to e) being 100% by weight, and B) at least one active ingredient.
    Type: Grant
    Filed: June 3, 2008
    Date of Patent: September 10, 2019
    Assignee: BASF SE
    Inventors: Karl Kolter, Michael Schönherr, Silke Gebert, Kathrin Meyer-Böhm, Angelika Maschke
  • Patent number: 10398652
    Abstract: Method for producing sodium bicarbonate particles by spray-drying of an aqueous solution comprising 1 to 10% by weight of sodium bicarbonate and an additive selected from the group consisting of: magnesium salt, sodium alkylbenzene sulfonate and soybean lecithin. Sodium bicarbonate particles obtainable by such process and comprising at least 20 mg of the additive per kg of sodium bicarbonate particles.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: September 3, 2019
    Assignee: Solvay SA
    Inventor: David Jean Lucien Savary
  • Patent number: 10391094
    Abstract: Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: August 27, 2019
    Assignee: Impact Biomedicines, Inc.
    Inventors: Arvind Jayan, Janice Cacace
  • Patent number: 10383797
    Abstract: Goniochromatic/light reflecting cosmetic compositions well suited for making up the skin, lips, hair or integuments, contain (a) at least one goniochromatic coloring agent suited for creating a goniochromatic colored background and (b) an amount of light reflective particles suited for creating highlight points that are visible to the naked eye, formulated into (c) a topically applicable, physiologically acceptable medium therefor.
    Type: Grant
    Filed: January 11, 2010
    Date of Patent: August 20, 2019
    Assignee: SOCIETE L'OREAL SA
    Inventors: Jean-Christophe Simon, Franck Girier-Dufournier, Patricia Lemann
  • Patent number: 10385012
    Abstract: The invention relates to the use of a compound of formula (I) or a salt thereof for combating animal pests, where the symbols and indices are defined in the specification.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: August 20, 2019
    Assignee: BASF SE
    Inventors: Sebastian Soergel, Pascal Bindschaedler, Matthias Pohlman, Ralph Paulini
  • Patent number: 10369142
    Abstract: The invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form and an opioid analgesic agent which may be in an extended release, sustained release, modified release, or controlled release form and methods of preparing such a combination dosage form.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: August 6, 2019
    Inventors: Shaoling Li, Manshiu Leung, Hao Zhang, Venkat R. Thalladi, Yun Mo
  • Patent number: 10362789
    Abstract: To provide a method which shows excellent effects in controlling pests in a field of soybean, corn or cotton. A method for controlling weeds in a field of soybean, corn or cotton, wherein the field of soybean, corn or cotton is treated with at least one PPO-inhibiting compound selected from the group consisting of flumioxazin, sulfentrazone, saflufenacil, oxyfluorfen, fomesafen-sodium, and the compound of the formula (I): before, at or after seeding with a seed of soybean, corn or cotton treated with one or more nematicides.
    Type: Grant
    Filed: March 7, 2017
    Date of Patent: July 30, 2019
    Inventor: Yoshinao Sada
  • Patent number: 10362800
    Abstract: The present invention relates to improved vitamin E formulations, as well as to the production of such formulations.
    Type: Grant
    Filed: December 27, 2011
    Date of Patent: July 30, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Martin Gadient, Thomas Lindemann, Mischa Schwaninger, Karl Manfred Voelker, Kai Urban, Stefanie Kirchen
  • Patent number: 10350334
    Abstract: The present invention includes a catheter locking solution having both antimicrobial and anticoagulant properties including a local anesthetic and a viscosifying agent. The local anesthetic of the present invention may be an amino amide; an amino ester; an aminoacylanilide; an aminoalkyl benzoate; an amino carbonate; an N-phenylamidine compound; an N-aminoalkyl amid; an aminoketone, or combinations and mixtures thereof. In a particular embodiment of the present invention, the local anesthetic is tetracaine or dibucaine.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: July 16, 2019
    Assignee: Becton, Dickinson and Company
    Inventors: John J. Kelley, III, Thelma I. Valdes
  • Patent number: 10350157
    Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: July 16, 2019
    Inventors: Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Amy T. Lu, Daniel J. Myers, Joshua D. Rabinowitz, Martin J. Wensley, Jeffrey A. McKinney, Alejandro C. Zaffaroni
  • Patent number: 10342895
    Abstract: A pulverulent semisynthetic material, derived from a natural marine biomaterial, namely the aragonitic inner layer of the shell of bivalve molluscs selected from the group including Pinctadines, notably Pinctada maxima, margaritifera, and Tridacnes, notably Tridacnagigas, maxima, derasa, tevaroa, squamosa, crocea, Hippopushippopus, Hippopusporcelanus, in pulverulent form, with addition of insoluble and soluble biopolymers and calcium carbonate transformed by carbonation; it also relates to the method of preparation thereof and to the uses thereof.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: July 9, 2019
    Assignee: MBP (MAURITIUS) LTD
    Inventors: Georges Camprasse, Serge Camprasse
  • Patent number: 10342830
    Abstract: This document provides methods and materials for treating lung conditions induced by inhalable insulin therapy. For example, compositions including a dried amnion tissue preparation and/or a dried stem cell preparation as well as methods for using such compositions to treat inhalable insulin induced lung conditions are provided.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: July 9, 2019
    Inventor: Gary M. Petrucci
  • Patent number: 10342938
    Abstract: A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, peptides and proteins such as insulin and glucagon-like peptide 1 for the treatment of endocrine disease, for example, diabetes and/or obesity.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: July 9, 2019
    Assignee: MannKind Corporation
    Inventors: Chad C. Smutney, Benoit Adamo, John M. Polidoro, P. Spencer Kinsey, Dennis Overfield, Carl R. Sahi, Christine Billings, Mark T. Marino
  • Patent number: 10321681
    Abstract: A plant supporting formulation which is also suitable for use as a delivery vehicle, or a component of a delivery vehicle, for the delivery of one or more phytologically beneficial substances to a plant, and for enhancing the translocation of such delivered substance(s) in or on the plant, the formulation comprising a micro-emulsion constituted by a dispersion of vesicles or microsponges of a fatty acid based component in an aqueous carrier, the fatty acid based component comprising at least one long chain fatty acid based substance selected from the group consisting of free fatty acids and derivatives of free fatty acids. The dispersion is preferably characterized in that at least 50% of the vesicles or microsponges are of a diametrical size of between 50 nm and 5 micrometer. The dispersion is further also characterized in that the micro-emulsion has a zeta potential of between ?25 mV and ?60 mV.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: June 18, 2019
    Inventor: Anne Frederica Grobler
  • Patent number: 10314839
    Abstract: The present invention provides a composition comprising an opioid agonist, and a polymer-antagonist conjugate. The polymer-antagonist conjugate preferably does not hydrolyze upon administration to a patient, and does not bind to the opioid receptors. The covalent bond between the polymer and the antagonist in the conjugate is broken over a defined period of time to release the antagonist into the formulation. The released antagonist attenuates the liking of the agonist, thereby eliminating the incentive to the diversion of the medicines.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: June 11, 2019
    Assignee: Elysium Therapeutics, Inc.
    Inventor: Thomas E. Jenkins
  • Patent number: 10301295
    Abstract: The present invention relates to a compound of formula (I) wherein: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and G are as defined herein; and wherein the compound of formula (I) is optionally present as an agrochemically acceptable salt thereof. These compounds are thought to be suitable for use as herbicides. The invention therefore also relates to a method of controlling weeds, especially grassy monocotyledonous weeds, in crops of useful plants, comprising applying a compound of formula (I), or a herbicidal composition comprising such a compound, to the plants or to the locus thereof.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: May 28, 2019
    Inventors: Shuji Hachisu, Alan Joseph Hennessy, Jeffrey Steven Wailes, Nigel James Willetts, Christopher John Mathews, Janice Black, Suzanna Jane Dale
  • Patent number: 10299476
    Abstract: The invention relates to a novel class of (S)-3?-substituted-abscisic acid derivatives and (±)-3?-substituted-abscisic acid derivatives, and methods of synthesizing the derivatives.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: May 28, 2019
    Inventors: Gary T. Wang, Daniel F. Heiman, Gregory D. Venburg, Eiki Nagano, Marci Surpin, Joseph H. Lustig
  • Patent number: 10287615
    Abstract: The present invention relates to a process for selectively producing sophorolactone without use of organic solvent, comprising the steps of: —pre-cultivating cells of a Candida species capable of producing sophorolactone, in absence of an oily substrate until a stationary growth phase is obtained, —cultivating said pre-cultivated cells in an aqueous medium in the presence of at least one fermentable sugar and substrate; the reaction mixture of sugar, substrate and pre-cultivated cells being present in an amount and conditions such that the cells metabolize the sugar and substrate thereby forming sophorolactone and fatty acid, —continuously feeding said substrate to said cells thereby suppressing the formation of fatty acid and keeping fatty acid levels in the reaction mixture below 10 g/l, resulting in the crystallization of at least part of the sophorolactone present in the reaction mixture, —warming the reaction mixture to a temperature between 60° C. and 90° C.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: May 14, 2019
    Inventors: Dirk Develter, Steve Fleurackers
  • Patent number: 10285404
    Abstract: Herbicidal concentrate compositions containing glyphosate salts and tank mix compositions containing a combination of glyphosate salt and dicamba salt herbicides are described. A method of preparing a tank mix composition comprising a glyphosate component and a dicamba component is also described. The method includes combining a glyphosate concentrate composition, a dicamba composition comprising one or more salts of dicamba and dilution water to form the tank mix composition. The glyphosate concentrate composition comprises a glyphosate salt selected from the group consisting of the monoethanolamine salt, the potassium salt, and mixtures thereof at a glyphosate loading of at least about 240 grams acid equivalent per liter (g a.e./l), and the pH of a 5 wt. % acid equivalent dilution of the glyphosate concentrate composition is from about 5 to about 6.5.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: May 14, 2019
    Assignee: Monsanto Technology LLC
    Inventors: John Hemminghaus, Alison MacInnes
  • Patent number: 10285916
    Abstract: A strip of material for the delivery of an oral care active is disclosed. The strip of material includes a structural elastic-like film backing layer including a strainable network having a first region and a second region formed of substantially the same material composition, the first region providing a first, elastic-like resistive force to an applied axial elongation, and the second region providing a second distinctive resistive force to further applied axial elongation, thereby providing at least two stages of resistive forces in use; and an oral care composition disposed on the film, the oral care composition including an oral care active.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: May 14, 2019
    Assignee: The Procter & Gamble Company
    Inventors: Paul Albert Sagel, Jean Jianqun Zhao, Lan Ngoc Nguyen